Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.
about
Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation17beta-Estradiol responsiveness of MCF-7 laboratory strains is dependent on an autocrine signal activating the IGF type I receptorPrenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer.Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cellsPI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cellsc-Src-null mice exhibit defects in normal mammary gland development and ERalpha signalingTwo domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cellsThe inhibition of p85αPI3KSer83 phosphorylation prevents cell proliferation and invasion in prostate cancer cells.Oestrogen receptors, receptor variants and oestrogen actions in the hypothalamic-pituitary axis.A mechanistic study of the effect of doxorubicin/adriamycin on the estrogen response in a breast cancer modelNovel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.Membrane initiated estrogen signaling in breast cancer.The classical progesterone receptor mediates Xenopus oocyte maturation through a nongenomic mechanism.Signal transduction through the Ras/Erk pathway is essential for the mycoestrogen zearalenone-induced cell-cycle progression in MCF-7 cells.Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol.MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4.CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin.Distinct signaling pathways mediate stimulation of cell cycle progression and prevention of apoptotic cell death by estrogen in rat pituitary tumor PR1 cellsAndrogen-induced cell migration: role of androgen receptor/filamin A associationProgestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cellsQuantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways.Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 functionOestrogen receptor-alpha regulates non-canonical Hedgehog-signalling in the mammary gland.Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes.Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling.Progestin upregulates G-protein-coupled receptor 30 in breast cancer cells.Extracellular signal-regulated kinase 8 (ERK8) controls estrogen-related receptor α (ERRα) cellular localization and inhibits its transcriptional activity.Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells.Cell localization, physiology, and nongenomic actions of estrogen receptors.Diversity in the mechanisms of gene regulation by estrogen receptors.Epigenomic reprogramming of the developing reproductive tract and disease susceptibility in adulthoodNon-genomic actions of androgens.Targeting androgen receptor/Src complex impairs the aggressive phenotype of human fibrosarcoma cells.Endocrine-responsive breast cancer and strategies for combating resistance.Non-nuclear actions of estrogen: new targets for prevention and treatment of cardiovascular disease.PAX2 is activated by estradiol in breast cancer cells of the luminal subgroup selectively, to confer a low invasive phenotype.Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation.The biology of progesterone receptor in the normal mammary gland and in breast cancer
P2860
Q24631073-FC36FDAA-49E3-497F-8EB4-59D201CC95E4Q24792340-E6F30D6B-64F1-474A-9754-761AFA3C3587Q24796687-42250DF1-F91C-4FAA-93FB-317A55EDDC59Q24803054-E12C78EB-53FE-4FC3-90F0-F6DBB151FB08Q28203389-89D93AFB-FBD9-408F-93C1-DC9BC6034677Q28363087-B35CA3EA-A497-47F4-BD3B-6951D65510C0Q28504741-8FFD43D3-E88C-462B-80BE-558DA0DF664BQ28771752-FAB5D9E5-4DE7-46ED-859E-39E6B9380728Q30009887-18249BA2-1141-4F9E-8183-79958C1DF573Q30308731-F91D0D26-C718-4892-8F3C-42764CDDDE06Q30417300-F9313B90-45A7-4913-9FA2-E44990E3F07AQ30435726-8A841BE5-D5C7-4E43-AB5D-D2D26DBCF017Q30439082-90700351-3248-429D-91A0-54AD52C66E2CQ30439994-45816040-7350-4919-918C-00601694F93DQ30950816-B0DCAA1A-D013-400D-AAB7-3205CD9719C0Q32163249-1D4E0BEC-C74C-4C49-990E-018AB3DE0CC7Q33564705-03069C50-2350-4F11-BDE0-79B56EA425C5Q33641949-E872893D-84A3-4CC0-A572-DFF49A14FE01Q33654819-31B89CA6-4023-46C0-9D3E-44A52C58B843Q33763624-BA2D9FCD-1F2C-46ED-95C5-48119020680FQ33831959-C47CD924-5119-482F-8D19-7301913D1B7BQ33836927-3944EF89-21A5-4D66-B992-E67C8D5F5437Q33947416-78E65470-9232-412C-9488-4EC045411524Q33967106-F8987118-255D-44F5-B526-9EA469D05275Q34038494-E767C393-50E2-4798-8BF3-4DFCD36FD783Q34064060-E76FE6D6-3FEA-469E-9CCE-A744BFFF0C08Q34125163-14BB9EE7-B2E8-46AF-8420-2B353FED34FEQ34129948-DF84BF9E-2995-4FBB-811A-DCF4397818EDQ34156903-D50229C1-B53F-4E8A-AC62-255C4C8E2802Q34168767-4501B028-C411-4BDD-8220-9F9323B1C3C6Q34377346-DF18DD01-9B23-4684-8452-C7BB6C7C8754Q34561503-F8D4F38E-266C-41DF-90EE-4359E95B8634Q34703672-DC1F9BE1-E06F-4F0E-842D-90EFC525FD94Q34727863-3B0EF0FD-E47D-424A-87E5-9C3B85E3434AQ35018614-DB509787-1704-48F9-A246-7C5EDC148B44Q35084786-D58C345C-28CB-49B5-9EDE-2E366C6A3F49Q35679460-534FAE0C-5A14-40DF-86CB-9C3E4F609160Q35690099-FD455FFB-D370-4ECC-B032-0F482673E7C3Q35843050-9ACB60AF-B2F2-4873-ACA9-04C495F0FE7AQ35868802-9994B7CE-405F-4D02-9B1A-A39C549C06DC
P2860
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.
@ast
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.
@en
type
label
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.
@ast
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.
@en
prefLabel
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.
@ast
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.
@en
P2860
P50
P356
P1433
P1476
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis
@en
P2093
D Ametrano
F Auricchio
P2860
P304
P356
10.1093/EMBOJ/18.9.2500
P407
P577
1999-05-01T00:00:00Z